Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 455

1.

Repeated thrombolysis in a patient with a thrombosed tricuspid valve prosthesis.

Flottmann C, Gottfried-Kwasniok R, Scholtz W, Horstkotte D.

Clin Res Cardiol. 2018 May 9. doi: 10.1007/s00392-018-1271-x. [Epub ahead of print] No abstract available.

PMID:
29744619
2.

Characteristics and circadian distribution of cardiac arrhythmias in patients with heart failure and sleep-disordered breathing.

Omran H, Bitter T, Horstkotte D, Oldenburg O, Fox H.

Clin Res Cardiol. 2018 May 8. doi: 10.1007/s00392-018-1269-4. [Epub ahead of print]

PMID:
29740701
3.

Adaptive servo-ventilation to treat central sleep apnea in heart failure with reduced ejection fraction: the Bad Oeynhausen prospective ASV registry.

Oldenburg O, Wellmann B, Bitter T, Fox H, Buchholz A, Freiwald E, Horstkotte D, Wegscheider K.

Clin Res Cardiol. 2018 Aug;107(8):719-728. doi: 10.1007/s00392-018-1239-x. Epub 2018 Apr 13.

PMID:
29654439
4.

Cycle length identifies obstructive sleep apnea and central sleep apnea in heart failure with reduced ejection fraction.

Bitter T, Özdemir B, Fox H, Horstkotte D, Oldenburg O.

Sleep Breath. 2018 Apr 10. doi: 10.1007/s11325-018-1652-4. [Epub ahead of print]

PMID:
29637409
5.

Valve-in-valve transcatheter aortic valve implantation with CoreValve/Evolut R© for degenerated small versus bigger bioprostheses.

Scholtz S, Piper C, Horstkotte D, Gummert J, Ensminger SM, Börgermann J, Scholtz W.

J Interv Cardiol. 2018 Jun;31(3):384-390. doi: 10.1111/joic.12498. Epub 2018 Feb 28.

PMID:
29490430
6.

Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.

Burghardt A, van Buuren F, Dimitriadis Z, Grübbel T, Seggewiss H, Scholtz S, Horstkotte D, Faber L.

Clin Res Cardiol. 2018 Jun;107(6):479-486. doi: 10.1007/s00392-018-1209-3. Epub 2018 Feb 16.

PMID:
29453593
7.

Impact of procedure-related conduction disturbances after transcatheter aortic valve implantation on myocardial performance and survival evaluated by conventional and speckle tracking echocardiography.

Dimitriadis Z, Scholtz S, Scholtz W, Wiemer M, Piper C, Ensminger S, Fox H, Horstkotte D, Faber L.

Echocardiography. 2018 May;35(5):621-631. doi: 10.1111/echo.13823. Epub 2018 Feb 13.

PMID:
29437242
8.

Noninvasive pulse contour analysis for determination of cardiac output in patients with chronic heart failure.

Roth S, Fox H, Fuchs U, Schulz U, Costard-Jäckle A, Gummert JF, Horstkotte D, Oldenburg O, Bitter T.

Clin Res Cardiol. 2018 May;107(5):395-404. doi: 10.1007/s00392-017-1198-7. Epub 2018 Jan 19.

PMID:
29352326
9.

Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.

Veselka J, Faber L, Jensen MK, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg J, Liebregts M.

Can J Cardiol. 2018 Jan;34(1):16-22. doi: 10.1016/j.cjca.2017.10.020.

PMID:
29275877
10.

Second generation cryoballoon ablation for persistent atrial fibrillation: an updated meta-analysis.

Omran H, Gutleben KJ, Molatta S, Fischbach T, Wellmann B, Horstkotte D, Körber B, Nölker G.

Clin Res Cardiol. 2018 Feb;107(2):182-192. doi: 10.1007/s00392-017-1171-5. Epub 2017 Oct 26.

PMID:
29075979
11.

Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.

Liebregts M, Faber L, Jensen MK, Vriesendorp PA, Hansen PR, Seggewiss H, Horstkotte D, Adlova R, Michels M, Bundgaard H, Ten Berg JM, Veselka J.

Europace. 2017 Sep 18. doi: 10.1093/europace/eux251. [Epub ahead of print]

PMID:
29016960
12.

Characteristics of sleep-disordered breathing in patients with atrial fibrillation and preserved left ventricular ejection fraction.

Strotmann J, Fox H, Bitter T, Sauzet O, Horstkotte D, Oldenburg O.

Clin Res Cardiol. 2018 Feb;107(2):120-129. doi: 10.1007/s00392-017-1163-5. Epub 2017 Sep 23.

PMID:
28942524
13.

Predominant obstructive or central sleep apnea in patients with atrial fibrillation: influence of characterizing apneas versus apneas and hypopneas.

Strotmann J, Fox H, Bitter T, Schindhelm F, Gutleben KJ, Horstkotte D, Oldenburg O.

Sleep Med. 2017 Sep;37:66-71. doi: 10.1016/j.sleep.2017.06.003. Epub 2017 Jun 23.

PMID:
28899542
14.

Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device.

Dimitriadis Z, Scholtz W, Ensminger SM, Piper C, Bitter T, Wiemer M, Vlachojannis M, Börgermann J, Faber L, Horstkotte D, Gummert J, Scholtz S.

PLoS One. 2017 Aug 24;12(8):e0183658. doi: 10.1371/journal.pone.0183658. eCollection 2017.

15.

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case.

Fox H, Farr M, Horstkotte D, Flottmann C.

Case Rep Cardiol. 2017;2017:9231959. doi: 10.1155/2017/9231959. Epub 2017 Jul 12.

16.

[A 19-Year-Old Female Athlete with an Abnormal ECG].

Faber L, van Buuren F, Mellwig KP, Burchert W, Horstkotte D.

Dtsch Med Wochenschr. 2017 Jul;142(14):1027. doi: 10.1055/s-0043-102958. Epub 2017 Jul 20. German. No abstract available.

PMID:
28728196
17.

Transcatheter Aortic Valve Implantation in Nonagenarians: Procedural Outcome and Mid-Term Results.

Scholtz S, Dimitriadis Z, Vlachojannis M, Piper C, Horstkotte D, Wiemer M, Gummert J, Fujita B, Benzinger M, Ensminger SM, Börgermann J, Scholtz W.

Heart Lung Circ. 2018 Jun;27(6):725-730. doi: 10.1016/j.hlc.2017.05.137. Epub 2017 Jun 15.

PMID:
28690021
18.

A Rare Case of Cardiac Melanoma Mimicking Hypertrophic Cardiomyopathy.

Friedel I, Burchert W, Horstkotte D, Faber L.

Can J Cardiol. 2017 Jul;33(7):950.e1-950.e3. doi: 10.1016/j.cjca.2017.03.023. Epub 2017 Apr 6.

PMID:
28668146
19.

Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.

Liebregts M, Faber L, Jensen MK, Vriesendorp PA, Januska J, Krejci J, Hansen PR, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg JM, Veselka J.

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1134-1143. doi: 10.1016/j.jcin.2017.03.030.

20.

Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg J, Stables RH, Jensen MK.

J Am Heart Assoc. 2017 May 16;6(5). pii: e005735. doi: 10.1161/JAHA.117.005735.

21.

Impact of sleep-disordered breathing in patients with acute myocardial infarction: a retrospective analysis.

Gessner V, Bitter T, Horstkotte D, Oldenburg O, Fox H.

J Sleep Res. 2017 Oct;26(5):657-664. doi: 10.1111/jsr.12540. Epub 2017 May 10.

PMID:
28488317
22.

Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients.

Fox H, Bitter T, Horstkotte D, Oldenburg O.

Sleep Med Clin. 2017 Jun;12(2):229-241. doi: 10.1016/j.jsmc.2017.01.003. Epub 2017 Mar 9. Review.

PMID:
28477777
23.

Impairment of pulmonary diffusion correlates with hypoxemic burden in central sleep apnea heart failure patients.

Fox H, Koerber B, Bitter T, Horstkotte D, Oldenburg O.

Respir Physiol Neurobiol. 2017 Sep;243:7-12. doi: 10.1016/j.resp.2017.04.011. Epub 2017 Apr 30.

PMID:
28467884
24.

Sleep duration and quality in heart failure patients.

Türoff A, Thiem U, Fox H, Spießhöfer J, Bitter T, Tamisier R, Punjabi NM, Horstkotte D, Oldenburg O.

Sleep Breath. 2017 Dec;21(4):919-927. doi: 10.1007/s11325-017-1501-x. Epub 2017 Apr 7.

PMID:
28389910
25.

[Catheter-Based Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up 1996-2016].

Faber L, Gleichmann U, Horstkotte D, Seggewiss H.

Dtsch Med Wochenschr. 2017 Feb;142(4):276-281. doi: 10.1055/s-0042-121855. Epub 2017 Feb 24. German.

PMID:
28235228
26.

Lipoprotein (a) and coronary heart disease - is there an efficient secondary prevention?

Mellwig KP, Horstkotte D, van Buuren F.

Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):18-21. doi: 10.1007/s11789-017-0088-x.

27.

Incidence of elevated lipoprotein (a) levels in a large cohort of patients with cardiovascular disease.

van Buuren F, Horstkotte D, Knabbe C, Hinse D, Mellwig KP.

Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):55-59. doi: 10.1007/s11789-017-0087-y.

28.

Long-Term Experience with First-Generation Implantable Neurostimulation Device in Central Sleep Apnea Treatment.

Fox H, Bitter T, Horstkotte D, Oldenburg O, Gutleben KJ.

Pacing Clin Electrophysiol. 2017 May;40(5):498-503. doi: 10.1111/pace.13049. Epub 2017 Mar 28.

PMID:
28211952
29.

Resolution of Cheyne-Stokes Respiration after Treatment of Heart Failure with Sacubitril/Valsartan: A First Case Report.

Fox H, Bitter T, Horstkotte D, Oldenburg O.

Cardiology. 2017;137(2):96-99. doi: 10.1159/000455118. Epub 2017 Feb 9.

PMID:
28178694
30.

Impact of closure devices on vascular complication and mortality rates in TAVI procedures.

Dimitriadis Z, Scholtz W, Börgermann J, Wiemer M, Piper C, Vlachojannis M, Gummert J, Horstkotte D, Ensminger S, Faber L, Scholtz S.

Int J Cardiol. 2017 Aug 15;241:133-137. doi: 10.1016/j.ijcard.2017.01.088. Epub 2017 Jan 15.

PMID:
28153535
31.

Positive airway pressure therapy in heart failure patients: Long-term effects on lung function.

Fox H, Witzel S, Bitter T, Horstkotte D, Oldenburg O.

Respir Physiol Neurobiol. 2017 Apr;238:41-46. doi: 10.1016/j.resp.2017.01.010. Epub 2017 Jan 23.

PMID:
28126479
32.

Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.

Zeng Y, Cavalcante R, Tenekecioglu E, Suwannasom P, Sotomi Y, Collet C, Abdelghani M, Jonker H, Digne F, Horstkotte D, Zehender M, Indolfi C, Saia F, Fiorilli R, Chevalier B, Bolognese L, Goicolea J, Nie S, Onuma Y, Serruys PW; investigators of Absorb II study.

Int J Cardiovasc Imaging. 2017 Apr;33(4):441-449. doi: 10.1007/s10554-016-1033-7. Epub 2016 Dec 23.

33.

Improvements of central respiratory events, Cheyne-Stokes respiration and oxygenation in patients hospitalized for acute decompensated heart failure.

Basic K, Fox H, Spießhöfer J, Bitter T, Horstkotte D, Oldenburg O.

Sleep Med. 2016 Nov - Dec;27-28:15-19. doi: 10.1016/j.sleep.2016.10.006. Epub 2016 Oct 28.

PMID:
27938912
34.

Left ventricular adaptation after TAVI evaluated by conventional and speckle-tracking echocardiography.

Dimitriadis Z, Scholtz S, Ensminger S, Wiemer M, Fischbach T, Scholtz W, Piper C, Börgermann J, Bitter T, Horstkotte D, Faber L.

Int J Cardiol. 2017 Feb 1;228:633-637. doi: 10.1016/j.ijcard.2016.11.035. Epub 2016 Nov 9.

PMID:
27883973
35.

Prevalence of Sleep-Disordered Breathing and Patient Characteristics in a Coronary Artery Disease Cohort Undergoing Cardiovascular Rehabilitation.

Fox H, Purucker HC, Holzhacker I, Tebtmann U, Bitter T, Horstkotte D, Graml A, Woehrle H, Oldenburg O.

J Cardiopulm Rehabil Prev. 2016 Nov/Dec;36(6):421-429.

PMID:
27490427
36.

[Homozygous hypercholesterolemia - new therapeutic options in cases with complete lack of LDL- receptor].

Mellwig KP, Farr M, Diekmann J, Horstkotte D, van Buuren F.

Dtsch Med Wochenschr. 2016 Jun;141(12):878-81. doi: 10.1055/s-0041-109013. Epub 2016 Jun 15. German.

PMID:
27305304
37.

Reduction of radiation exposure in cryoballoon ablation procedures: a single-centre study applying intracardiac echocardiography and other radioprotective measures.

Rubesch-Kütemeyer V, Molatta S, Vogt J, Gutleben KJ, Horstkotte D, Nölker G.

Europace. 2017 Jun 1;19(6):947-953. doi: 10.1093/europace/euw139.

PMID:
27256413
38.

Bilateral antegrade perfusion of the superficial femoral artery to prevent limb ischaemia during combined use of Impella CP left ventricular assist device and extracorporeal life support.

Kizner L, Flottmann C, Horstkotte D, Gummert J.

Interact Cardiovasc Thorac Surg. 2016 Aug;23(2):335-7. doi: 10.1093/icvts/ivw115. Epub 2016 Apr 29.

PMID:
27130716
39.

First Explantation of Direct Flow Medical Transcatheter Valve.

Scholtz S, Horstkotte D, Gummert J, Börgermann J, Scholtz W.

J Heart Valve Dis. 2015 May;24(3):342-4.

PMID:
26901910
40.

Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure-a randomized, controlled, double-blind, crossover trial.

Bitter T, Fox H, Schmalgemeier H, Wellmann B, Zwenke A, Spiesshöfer J, Dimitriadis Z, Horstkotte D, Oldenburg O.

Sleep Breath. 2016 May;20(2):795-804. doi: 10.1007/s11325-015-1300-1. Epub 2016 Jan 19.

PMID:
26782102
41.

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

Veselka J, Jensen MK, Liebregts M, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Tomasov P, Adlova R, Bundgaard H, Steggerda R, Ten Berg J, Faber L.

Eur Heart J. 2016 May 14;37(19):1517-23. doi: 10.1093/eurheartj/ehv693. Epub 2016 Jan 7.

PMID:
26746632
42.

Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients.

Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U, Horstkotte D, Wegscheider K.

Eur Heart J. 2016 Jun 1;37(21):1695-703. doi: 10.1093/eurheartj/ehv624. Epub 2015 Nov 26.

PMID:
26612581
43.

Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea.

Fox H, Bitter T, Horstkotte D, Oldenburg O.

Clin Res Cardiol. 2016 May;105(5):451-9. doi: 10.1007/s00392-015-0940-2. Epub 2015 Nov 9.

PMID:
26552903
44.

Heart failure: Central sleep apnoea in HF--what can we learn from SERVE-HF?

Oldenburg O, Horstkotte D.

Nat Rev Cardiol. 2015 Dec;12(12):686-7. doi: 10.1038/nrcardio.2015.168. Epub 2015 Nov 3. No abstract available.

PMID:
26525541
45.

Interventional ASD II closure in the presence of an abnormally localized left main coronary artery.

Bogunovic N, Scholtz W, Horstkotte D, van Buuren F.

Clin Res Cardiol. 2016 Feb;105(2):182-5. doi: 10.1007/s00392-015-0923-3. Epub 2015 Oct 1. No abstract available.

PMID:
26428516
46.

Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne-Stokes respiration compared to healthy volunteers.

Spießhöfer J, Fox H, Lehmann R, Efken C, Heinrich J, Bitter T, Körber B, Horstkotte D, Oldenburg O.

Heart Vessels. 2016 Jul;31(7):1117-30. doi: 10.1007/s00380-015-0717-6. Epub 2015 Aug 22.

PMID:
26296413
47.

[Aortic valve endocarditis: diagnosis and therapy].

Piper C, Faber L, Horstkotte D.

Dtsch Med Wochenschr. 2015 Jun;140(13):967. doi: 10.1055/s-0041-103102. Epub 2015 Jun 26. German. No abstract available.

PMID:
26115126
48.

Radiation protection during cardiac catherization: development of an improved lead apron for periinterventional echocardiography.

Bogunovic N, Horstkotte D, Faber L, Bogunovic L, Van Buuren F.

Minerva Cardioangiol. 2015 Oct;63(5):458-9. Epub 2015 Jun 26. No abstract available.

PMID:
26112279
49.

[Erratum to: "Infective Endocarditis"].

Horstkotte D, Piper C.

Herz. 2015 Jun;40(4):637-8. doi: 10.1007/s00059-015-4236-0. German. No abstract available.

PMID:
26077776
50.

Echocardiographically derived effective valve opening area in mitral prostheses: a comparative analysis of various calculations using continuity equation and pressure half time method.

Bogunovic N, Horstkotte D, Faber L, Bogunovic L, van Buuren F.

Heart Vessels. 2016 Jun;31(6):932-8. doi: 10.1007/s00380-015-0690-0. Epub 2015 Jun 7.

PMID:
26049365

Supplemental Content

Loading ...
Support Center